Breaking News

Tweet TWEET

Corcept Therapeutics to Announce Third Quarter 2013 Financial Results and Host Conference Call

Corcept Therapeutics to Announce Third Quarter 2013 Financial Results and Host 
Conference Call 
MENLO PARK, CA -- (Marketwired) -- 11/04/13 --  Corcept Therapeutics
Incorporated (NASDAQ: CORT) today announced it will report third
quarter 2013 financial results on November 7, 2013. The Company will
host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m.
Pacific Time).  
Conference Call Information 
To participate, dial 1-888-771-4371 from the United States or
+1-847-585-4405 internationally approximately 10 minutes before the
start of the call. The passcode is 35967600.  
A replay will be available through November 21, 2013 at
1-888-843-7419 from the United States and +1-630-652-3042
internationally. The passcode is 35967600.  
About Corcept Therapeutics Incorporated 
Corcept is a pharmaceutical company engaged in the discovery,
development and commercialization of drugs for the treatment of
severe metabolic and psychiatric disorders. Korlym, a first
generation competitive GR-II antagonist, is the company's first
FDA-approved medication. The company has a phase 3 trial underway for
mifepristone for treatment of the psychotic features of psychotic
depression and a portfolio of selective GR-II antagonists that
competitively block the effects of cortisol but not progesterone. It
owns extensive intellectual property covering the use of GR-II
antagonists, including mifepristone, in the treatment of a wide
variety of metabolic, psychiatric and other disorders. It also holds
composition of matter patents for its selective GR-II antagonists. 
CONTACT:
Charles Robb
Chief Financial Officer
Corcept Therapeutics
650-688-8783
crobb@corcept.com
www.corcept.com 
 
 
Press spacebar to pause and continue. Press esc to stop.